ChemAxon

ChemAxon is a long-established, private software company that develops cheminformatics and AI-driven tools for the life sciences industry, primarily serving drug discovery researchers. Its technology enables the management, visualization, and analysis of chemical and biological data, accelerating early-stage R&D. As part of Certara since its acquisition, ChemAxon's offerings are integrated into a broader suite of modeling, simulation, and regulatory solutions. The company operates on a platform business model, generating revenue through software licensing and services to biotech, pharma, and CROs globally.

Suite of cheminformatics software and AI tools for chemical structure management, property prediction, database search, and data analysis, integrated into a broader drug development platform.

Competes with established commercial software vendors like Dassault Systèmes BIOVIA and Schrödinger, as well as popular open-source toolkits like RDKit. Its differentiation lies in its deep, specialized functionality, long-standing user base, and integration within Certara's end-to-end development platform.